Autopsy report · NCT00231192

Repaglinide for Adolescents With Cystic Fibrosis-Related Diabetes

“Unable to recruit any subjects”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Children's Hospital of Philadelphia

Sponsor type

University, hospital or other

Conditions

Diabetes

Interventions

Repaglinide and Insulin

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity
  “Not able to recruit subjects” (97% match in meaning)
• Recombinant Human Prolactin for Lactation Induction
  “Not able to recruit any subjects.” (93% match in meaning)
• Prospective Evaluation of Symptom Resolution in Acid Versus Non-acid Reflux Disease Following Anti-reflux Surgery
  “Unable to recruit a sufficient number of subjects.” (89% match in meaning)
• Whole-Food, Plant-Based Diet for Active Crohn's Disease
  “Difficulties with recruitment and unable to enroll any subjects” (86% match in meaning)
• A Pilot and Feasibility Study of Fecal Microbiota Transplantation for Ulcerative Colitis
  “Unable to recruit and enroll eligible subjects.” (85% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.